ArticleBMC medical imaging2025
Neurite orientation dispersion and density imaging reveals microstructural damage in moyamoya disease: a study based on tract- and gray-based spatial statistics.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
background and purposeThis study aims to comprehensively assess microstructural abnormalities in both gray matter (GM) and white matter (WM) in patients with moyamoya disease (MMD) using neurite orientation dispersion and density imaging (NODDI). The analysis integrates GM-based and tract-based spatial statistics (GBSS and TBSS, respectively).
methodsDiffusion-weighted imaging was performed on 26 healthy controls and 15 patients with MMD. NODDI metrics-including the neurite density index (NDI), orientation dispersion index (ODI), and isotropic volume fraction (ISOVF)-as well as diffusion tensor imaging (DTI) parameters-fractional anisotropy and mean diffusivity (MD)-were estimated and compared using GBSS and TBSS approaches.
resultsThe analysis revealed significant microstructural alterations in both GM and WM among patients with MMD. In GM, reduced ODI was observed in multiple regions, including areas associated with the default mode network, executive control network, visual cortex, auditory cortex, sensorimotor cortex, and insula. In WM, decreased NDI and increased ISOVF were identified, predominantly in the corpus callosum, corona radiata, and bilateral frontal and parietal lobes. Although both DTI and NODDI metrics showed similar spatial distribution patterns of WM changes, the alterations detected by NODDI were more widespread. This suggests that NODDI may provide superior sensitivity for identifying microstructural changes associated with MMD.
conclusionThe integration of NODDI with GBSS and TBSS enhances the detection of cerebral microstructural alterations in MMD. These findings highlight the potential of NODDI-based metrics as valuable imaging biomarkers for improving diagnostic accuracy in MMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.